Piperazines
Research News and Information

Saturday, November 21, 2009

Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL).

13 Dec 2009 BACKGROUND: Allogeneic hematopoietic cell transplant (HCT) with best available donor for children with Philadelphia positive (Ph+) acute lymphoblastic leukemia (ALL) has previously been considered standard practice. Since the introduction of ... Read more...

The treatment of pediatric Philadelphia positive (Ph+) leukemias in the imatinib era.

29 Nov 2009 BACKGROUND: As the treatment of Philadelphia positive (Ph+) leukemias in the era of imatinib continues to evolve, the role of allogeneic hematopoietic cell transplantation (allogeneic-HCT) in first remission is becoming more unclear. PROCEDURE: ... Read more...

Hemolytic anemia after zopiclone overdose.

30 Oct 2009 INTRODUCTION: Zopiclone is associated with methemoglobinemia. We report a case of zopiclone overdose manifested with another hematological complication, hemolysis. CASE: A 46-year-old woman overdosed with 50-100 tablets of 7.5 mg zopiclone. ... Read more...

Latest indexed articles for 'Piperazines'

These are the very latest articles for this heading:

• Allogeneic hematopoietic cell transplantation (allogeneic HCT) for treatment of pediatric Philadelphia chromosome-positive acute lymphoblastic leukemia (ALL). 13 Dec 2009
• The treatment of pediatric Philadelphia positive (Ph+) leukemias in the imatinib era. 29 Nov 2009
• Phosphodiesterase type 5 inhibitors for pulmonary arterial hypertension. 3 Nov 2009
• Hemolytic anemia after zopiclone overdose. 30 Oct 2009
• Ziprasidone and citalopram use in pregnancy and lactation in a woman with psychotic depression. 30 Oct 2009
• Radiosensitization effect of STI-571 on pancreatic cancer cells in vitro. 30 Oct 2009
• Cardiometabolic risk of second-generation antipsychotic medications during first-time use in children and adolescents. 26 Oct 2009
• Limited efficacy of imatinib in severe pulmonary chronic graft-versus-host disease. 20 Oct 2009
• Inhibition of poly(ADP-ribose) polymerase in BRCA mutation carriers. 20 Oct 2009
• Micelles for delivery of nitric oxide. 12 Oct 2009
• Discovery of novel protease activated receptors 1 antagonists with potent antithrombotic activity in vivo. 6 Oct 2009
• Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study. 3 Oct 2009
• Shifting paradigms: the seeds of oncogene addiction. 29 Sep 2009
• Attacking cancer at its foundation. 29 Sep 2009
• Perspectives on the development of imatinib and the future of cancer research. 29 Sep 2009
• Lasker Awards and papal portraiture: turning fields upside down. 29 Sep 2009
• Preserving fertility during cancer treatment. 29 Sep 2009
• Tumor lysis syndrome after starting treatment with Gleevec in a patient with chronic myelogenous leukemia. 29 Sep 2009
• Attenuation of risperidone-induced hyperprolactinemia with the addition of aripiprazole. 29 Sep 2009
• Prasugrel pharmacokinetics and pharmacodynamics in subjects with moderate renal impairment and end-stage renal disease. 29 Sep 2009

See a longer list of these articles.

Technical information about 'Piperazines'

Registry Number: 0

Descriptor UI: D010879

Alternative terms: Piperazines;

Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; blood; cerebrospinal fluid; chemical synthesis; classification; diagnostic use; economics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; poisoning; radiation effects; standards; supply & distribution; therapeutic use; toxicity; urine; chemistry; contraindications; agonists;

Tree Number: D03.383.606;